Terumo Co. (OTCMKTS:TRUMY – Get Free Report) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 61,900 shares, an increase of 217.4% from the March 15th total of 19,500 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 213,100 shares, the short-interest ratio is currently 0.3 days.
Terumo Stock Performance
Shares of OTCMKTS TRUMY opened at $18.37 on Thursday. Terumo has a 52 week low of $14.06 and a 52 week high of $21.22. The stock has a market capitalization of $27.20 billion, a PE ratio of 39.68 and a beta of 0.76. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.70 and a current ratio of 2.94. The stock has a 50 day moving average price of $18.33 and a 200 day moving average price of $19.08.
Terumo (OTCMKTS:TRUMY – Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $0.16 EPS for the quarter. The firm had revenue of $1.73 billion during the quarter.
Terumo Company Profile
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Featured Articles
- Five stocks we like better than Terumo
- Investing in Travel Stocks Benefits
- Goldman Sachs Just Revealed What’s Next for Markets
- How to trade penny stocks: A step-by-step guide
- Buy the Boeing Dip Even on Tariff and Bans?
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 3 High Short Interest Stocks Set to Pop After Tariff Fears Fade
Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.